The Combination Of Pixantrone, Etoposide, Bendamustine And, In Cd20+Tumors, Rituximab (Preben) Shows Promising Feasibility/Efficacy In Heavily Pre-Treated Aggressive Lymphomas Of B- And T-Cell Phenotype - Results Of The Pre-Trial Experience Leading To A Nordic Phase 1/2 Study (The Preben Trial)